Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa

Polymyxin Resistance ofPseudomonas aeruginosa phoQMutants Is Dependent on Additional Two-Component Regulatory Systems

(2013) Alina D. Gutu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates

(2013) Ji-Young Lee et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment

(2013) E. S. Snitkin et al.   GENOME RESEARCH

The Two-Component System CprRS Senses Cationic Peptides and Triggers Adaptive Resistance in Pseudomonas aeruginosa Independently of ParRS

(2012) Lucía Fernández et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of the Polymyxin B Resistome of Pseudomonas aeruginosa

(2012) Lucía Fernández et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymyxins and carbapenems from 1 patient

(2012) Ji-Young Lee et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients

(2011) Amanda K. Miller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients

(2011) Samuel M. Moskowitz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of Nonclonal Pseudomonas aeruginosa Isolates with Reduced Colistin Susceptibility in Korea

(2011) Ji-Young Lee et al.   Microbial Drug Resistance

A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams inPseudomonas aeruginosa

(2010) Cédric Muller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Adaptive Resistance to the "Last Hope" Antibiotics Polymyxin B and Colistin in Pseudomonas aeruginosa Is Mediated by the Novel Two-Component Regulatory System ParR-ParS

(2010) L. Fernandez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to polymyxins: Mechanisms, frequency and treatment options

(2010) Matthew E. Falagas et al.   DRUG RESISTANCE UPDATES

Involvement of pmrAB and phoPQ in Polymyxin B Adaptation and Inducible Resistance in Non-Cystic Fibrosis Clinical Isolates of Pseudomonas aeruginosa

(2009) K. N. Schurek et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

(2009) P. D. Lister et al.   CLINICAL MICROBIOLOGY REVIEWS

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients

(2008) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS